Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9206-9212

  Cho, Young Gyu ^a   Gordadze, Alexey V ^b   Ling, Paul D ^b   Wang, Fred ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; HERPES VIRUS; IMMUNE DEFICIENCY; IMMUNOBLOTTING; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 0032827260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9206-9212.1999     Document Type: Article

References (37)

1. Apolloni, A., and T. B. Sculley. 1994. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202:978-981.
2. Blake, N. W., A. Moghaddam, P. Rao, A. Kaur, R. Glickman, Y. Cho, A. Marchinim, T. Haigh, R. P. Johnson, A. B. Rickinson, and F. Wang. 1999. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. J. Virol. 73:7381-7389.
3. Cohen, J. I., F. Wang, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:2545-2554.
4. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
5. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
6. Dambaugh, T., F. Wang, K. Hennessy, E. Woodland, A. Rickinson, and E. Kieff. 1986. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J. Virol. 59:453-462.
7. Feichtinger, H., S. L. Li, E. Kaaya, P. Putkonen, K. Grunewald, K. Weyrer, D. Bottiger, I. Ernberg, A. Linde, G. Biberfeld, el al. 1992. A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired im-munodeficiency syndrome. J. Exp. Med. 176:281-286. (Erratum, 176:634.)
8. Frank, A., W. A. Andiman, and G. Miller. 1976. Epstein-Barr virus and nonhuman primates: natural and experimental infection. Adv. Cancer Res. 23:171-201.
9. Franken, M., B. Annis, A. N. Ali, and F. Wang. 1995. 5' coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Viral. 69:8011-8019.
10. Franken, M., O. Devergne, M. Rosenzweig, B. Annis, E. Kieff, and F. Wang. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
11. Gratama, J. W., M. A. Oosterveer, W. Weimar, K. Sintnicolaas, W. Sizoo, R. L. Bolhuis, and I. Ernberg. 1994. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J. Gen. Virol. 75: 85-94.
12. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
13. Heller, M., P. Gerber, and E. Kieff. 1981. Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J. Virol. 37:698-709.
14. Heller, M., and E. Kieff. 1981. Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. J. Virol. 37:821-826.
15. Lee, Y. S., A. Tanaka, R. Y. Lau, M. Nonoyama, and H. Rabin. 1980. Comparative studies of herpesvirus papio (baboon herpesvirus) DNA and Epstein-Barr virus DNA. J. Gen. Virol. 51:245-253.
16. Ling, P. D., and S. D. Hayward. 1995. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJK. J. Virol. 69:1944-1950.
17. Ling, P. D., J. J. Ryon, and S. D. Hayward. 1993. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J. Virol. 67:2990-3003.
18. Moghaddam, A., J. Koch, B. Annis, and F. Wang. 1998. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J. Virol. 72:3205-3212.
19. Moghaddam, A., M. Rosenzweig, D. Lee-Parritz, B. Annis, R. P. Johnson, and F. Wang. 1997. An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030-2033.
20. Peng, R., A. V. Gordadze, E. M. Fuentes Pannana, F. Wang, J. Zong, G. Hayward, J. Tan, and P. D. Ling. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovi-ruses. Submitted for publication.
21. Rabin, H., R. H. Neubauer, R. F. Hopkins, and B. M. Levy. 1977. Characterization of lymphoid cell lines established from multiple Epstein-Barr virus (EBV)-induced lymphomas in a cotton-topped marmoset. Int. J. Cancer 20:44-50.
22. Rangan, S. R., L. N. Martin, B. E. Bozelka, N. Wang, and B. J. Gormus. 1986. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int. J. Cancer. 38:425-432.
23. Rickinson, A. B., L. S. Young, and M. Rowe. 1987. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310-1317.
24. Rowe, M., L. S. Young, K. Cadwallader, L. Petti, E. Kieff, and A. B. Rickinson. 1989. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 63:1031-1039.
25. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092.
26. Sculley, T. B., A. Apolloni, L. Hurren, D. J. Moss, and D. A. Cooper. 1990. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J. Infect. Dis. 162:643-648.
27. Sculley, T. B., A. Apolloni, R. Stumm, D. J. Moss, N. Mueller-Lantczh, I. S. Misko, and D. A. Cooper. 1989. Expression of Epstein-Barr virus nuclear antigens 3,4, and 6 are altered in cell lines containing B-type virus. Virology 171:401-408.
28. Sculley, T. B., S. M. Cross, P. Borrow, and D. A. Cooper. 1988 Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. J. Infect. Dis. 158:186-192.
29. Sixbey, J. W., P. Shirley, P. J. Chesney, D. M. Buntin, and L. Resnick. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet ii: 761-765.
30. Walling, D. M., N. M. Clark, D. M. Markovitz, T. S. Frank, D. K. Braun, E. Eisenberg, D. J. Krutchkoff, D. H. Felix, and N. Raab-Traub. 1995. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J. Infect. Dis. 171:1122-1130.
31. Wang, F. Unpublished data.
32. Yalamanchili, R., S. Harada, and E. Kieff. 1996. The N-terminal half of EBNA2, except for seven pralines, is not essential for primary B-lymphocyte growth transformation. J. Virol. 70:2468-2473.
33. Yao, Q. Y., A. B. Rickinson, and M. A. Epstein. 1985. Oropharyngeal shedding of infectious Epstein-Barr virus in healthy virus-immune donors. A prospective study. Chin. Med. J. (Engl. Ed.). 98:191-196.
34. Yao, Q. Y., M. Rowe, B. Martin, L. S. Young, and A. B. Rickinson. 1991. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. Gen. Virol. 72:1579-1590.
35. Yates, J. L., S. M. Camiolo, S. Ali, and A. Ying. 1996. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222:1-13.
36. Young, L., C. Alfieri, K. Hennessy, H. Evans, O. H. C, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, et al. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
37. Zimber, U., H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-Doeberitz, G. Laux, C. Desgranges, P. Wittmann, U. K. Freese, U. Schneider, et al. 1986. Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66.